COMP <GO>
NTRA vs JNJ // EV/EBITDA & P/E VALUATION
Natera Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: NTRA 4
— JNJ 8
■ METRIC PARITY
LAST: $414.30 (-4.98%) • MKT CAP: $62.85B
valuation
—
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
valuation
18.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTRA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NTRA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.90% | 25.50% | -30.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.17% | 2.97% | -2.80 | JNJ | /fcf-yield <GO> |
| Operating Margin | -13.40% | 34.70% | -48.10 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -9.00% | 28.50% | -37.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 35.90% | 6.00% | +29.90 | NTRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.59 | +20.41 | NTRA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.20% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 60.4 | -3.53 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 1.08 | +0.01 | NTRA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 23.0x | -5.00 | NTRA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $62.85B | $662.49B | -$599.64B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NTRA REV | JNJ REV | NTRA GROSS % | JNJ GROSS % | NTRA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.31B | $94.19B | 44.0% | 67.9% | $109.1M | $19.70B |
| FY 2024 | $1.70B | $88.82B | 44.0% | 69.1% | $69.2M | $19.84B |
| FY 2023 | $1.08B | $85.16B | 44.0% | 44.0% | -$295.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTRA // BETA 1.09
JNJ // BETA 1.08